We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $417M
1-Year Est. Return 25.02%
This Fund
S&P 500
This Quarter Est. Return
-1.72%
1 Year Est. Return
+25.02%
3 Year Est. Return
+98.12%
5 Year Est. Return
+139.29%
10 Year Est. Return
+812.75%
AUM
$311M
AUM Growth
-$3.46M
Cap. Flow
+$5.64M
Cap. Flow %
1.82%
Top 10 Hldgs %
68.43%
Holding
57
New
10
Increased
22
Reduced
13
Closed
1

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.62M
2
URGN icon
UroGen Pharma
URGN
+$661K
3
NVDA icon
NVIDIA
NVDA
+$622K
4
ADBE icon
Adobe
ADBE
+$569K
5
AMZN icon
Amazon
AMZN
+$447K

Sector Composition

Rank Sector Weight
1 Technology 32.22%
2 Consumer Discretionary 29.76%
3 Healthcare 22.18%
4 Communication Services 12.19%
5 Industrials 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VZ icon
51
Verizon
VZ
$198B
$225K 0.07%
3,874
HON icon
52
Honeywell
HON
$77.9B
$217K 0.07%
+1,061
New +$207K
PLSE icon
53
Pulse Biosciences
PLSE
$2.27B
$209K 0.07%
+8,825
New +$264K
JNCE
54
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$103K 0.03%
+10,000
New +$110K
CMRX
55
DELISTED
Chimerix, Inc.
CMRX
$96K 0.03%
+10,000
New +$91.8K
SMMT icon
56
Summit Therapeutics
SMMT
$10.5B
$83K 0.03%
+14,059
New +$90.7K
VIPS icon
57
Vipshop
VIPS
$7.08B
-28,831
Closed -$6.81M

Similar funds

Bender Robert & Associates's Q1 2021 Portfolio in Review

As of Q1 2021, Bender Robert & Associates held 57 positions worth $311M, down 1.1% from $314M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Bender Robert & Associates's Q1 2021 filing shows 10 new, 22 increased, 13 reduced and 1 closed positions. Its largest new stake was Vertex Pharmaceuticals: 30,145 shares worth $6.48M. The largest sale was Vipshop, an estimated $6.81M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Bender Robert & Associates's largest Q1 2021 buy was Vertex Pharmaceuticals: 30,145 shares worth $6.48M.
  • Bender Robert & Associates added most to NVIDIA in Q1 2021, an estimated $622K increase.
  • Bender Robert & Associates's biggest Q1 2021 reduction was VMware, Inc, cutting an estimated $394K.
  • Bender Robert & Associates fully exited Vipshop in Q1 2021, selling an estimated $6.81M.
  • Bender Robert & Associates's ten largest holdings make up 68% of its $311M portfolio in Q1 2021.
  • Bender Robert & Associates opened 10 new positions and closed 1 in Q1 2021.
  • Bender Robert & Associates's portfolio value fell 1.1% quarter-over-quarter to $311M.

Based on Bender Robert & Associates's 13F filing for Q1 2021, filed 28 Apr 2021.